TH117318B - Wafers, which contain steroid hormones - Google Patents
Wafers, which contain steroid hormonesInfo
- Publication number
- TH117318B TH117318B TH601001401A TH0601001401A TH117318B TH 117318 B TH117318 B TH 117318B TH 601001401 A TH601001401 A TH 601001401A TH 0601001401 A TH0601001401 A TH 0601001401A TH 117318 B TH117318 B TH 117318B
- Authority
- TH
- Thailand
- Prior art keywords
- dosing
- steroid hormones
- hormones
- wafers
- steroid
- Prior art date
Links
- 239000003270 steroid hormone Substances 0.000 title abstract 4
- 235000012431 wafers Nutrition 0.000 title 1
- 210000004400 Mucous Membrane Anatomy 0.000 claims abstract 3
- 150000003431 steroids Chemical class 0.000 claims abstract 2
- 239000000969 carrier Substances 0.000 claims 2
- 239000001913 cellulose Substances 0.000 claims 2
- 229920002678 cellulose Polymers 0.000 claims 2
- 239000000463 material Substances 0.000 claims 2
- 108010010803 Gelatin Proteins 0.000 claims 1
- 229920000881 Modified starch Polymers 0.000 claims 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- 229920001577 copolymer Polymers 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 235000019426 modified starch Nutrition 0.000 claims 1
- 239000000454 talc Substances 0.000 claims 1
- 229910052623 talc Inorganic materials 0.000 claims 1
- 210000004369 Blood Anatomy 0.000 abstract 2
- 239000008280 blood Substances 0.000 abstract 2
- 229940088597 Hormone Drugs 0.000 abstract 1
- 230000000975 bioactive Effects 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Abstract
การประดิษฐ์เกี่ยวข้องกับสารผสมทางเภสัชกรรมในรูปของระบบในรูปของฟิล์มสำหรับการ ให้สเตียรอยด์ฮอร์โมนผ่านทางเยื่อเมือก ระบบการให้สำหรับสเตียรอยด์ ฮอร์โมนซึ่งละลายในปาก และซึ่งปลดปล่อยโดยมีชีวปริมาณออกฤทธิ์ที่สูงได้ถูกเปิดเผย ระบบการให้ยาในรูปของฟิล์มละลาย ในปาก ที่ต้องการแล้วในระยะเวลาน้อยกว่า 30 นาที และสเตียรอยด์ฮอร์โมนที่เข้าสู่กระแสเลือดผ่าน ทางเยื่อเมือกจากระบบการให้ยานำไปสู่การเพิ่มขึ้นของความเข้มข้นในเลือดอย่างรวดเร็ว ดังนั้นมัน เป็นไปได้ที่จะบรรลุผลความเข้มข้นสูงสุดของสเตียรอยด์ฮอร์โมนนี้ในเลือดในระยะเวลาน้อยกว่า 60 นาทีหลังการให้ยา The invention involves pharmaceutical mixtures as systems in the form of films for Providing steroid hormones through the mucous membranes. Dosage system for steroids Hormones which melt in the mouth And released with high bioactive content has been revealed. Dosage system is required in the form of a film dissolves in the mouth in less than 30 minutes and steroid hormones that enter the bloodstream through The mucous membrane from the dosing system leads to a rapid increase in its concentration in the blood, so it is possible to achieve the maximum concentration of this steroid hormone in the blood in a period of less than 60 minutes. After dosing
Claims (2)
Publications (2)
Publication Number | Publication Date |
---|---|
TH117318B true TH117318B (en) | 2012-11-15 |
TH117318A TH117318A (en) | 2012-11-15 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2006510655A5 (en) | ||
EA200702102A1 (en) | PLATES CONTAINING STEROID HORMONES | |
HRP20170864T1 (en) | Controlled release solid dose forms | |
Pichayakorn et al. | Deproteinised natural rubber used as a controlling layer membrane in reservoir-type nicotine transdermal patches | |
BRPI0513904A (en) | multiparticulate pharmaceutical form for low solubility active substances and a process for preparing the pharmaceutical form | |
JP2008534533A5 (en) | ||
JP2009536147A5 (en) | ||
EA201001244A1 (en) | SYSTEM OF DELIVERY OF MEDICINES WITH STABILIZING EFFECT | |
EA201100304A1 (en) | DELIVERY SYSTEM OF MEDICINES CONTAINING PROGESTINS | |
WO2012053006A8 (en) | Improved oral fast dissolving films comprising combination of polymers and method of preparation thereof | |
US20180104183A1 (en) | Oral film preparation | |
RU2018111690A (en) | ORAL DOSAGE FORM OF BUDESONID | |
DE502007003037D1 (en) | ACTIVE SUBSTANCE AND TRIMAGNESIUM DICITRATE STABILIZED SOLID MEDICAMENTS AND METHOD FOR THE PRODUCTION THEREOF CONTAINED AS DRYING AGENTS | |
CN104800183B (en) | A kind of Aspirin Enteric-coated Tablets and its preparation method and application | |
TH117318B (en) | Wafers, which contain steroid hormones | |
RU2018104691A (en) | COMPOSITIONS WITH MODIFIED NICERGOLINE RELEASE | |
MX2020005305A (en) | Pouch-type orally dissolving films with high active ingredient concentration. | |
Boyer | Tolvaptan and hyponatremia in a patient with cirrhosis | |
JP2019514970A5 (en) | ||
TH117318A (en) | Wafers, which contain steroid hormones | |
MY184297A (en) | Water soluble pharmaceutical film with enhanced stability | |
Hemchand et al. | New stability indicating RP-UFLC method for the simultaneous determination of Velpatasvir and Sofosbuvir in tablets | |
Amoako-Tuffour et al. | Permeation of losartan across human respiratory epithelium: an in vitro study with Calu-3 cells | |
WO2016014680A3 (en) | Oral transmucosal compositions including aromatase inhibitors for low testosterone levels in men | |
Higashino et al. | Effect of precipitation/re-dissolution processes from the supersaturated solution on the intestinal absorption of poorly water-soluble drugs |